Skip to main content
. 2020 Jun 30;11:989. doi: 10.3389/fphar.2020.00989

Table 4.

Clinical studies with antidiabetic and antihyperlipidemic essential oils.

Disease Authors Type of clinical study Number of patients Treatment Results
Diabetes mellitus Jafari et al., 2017 Randomized, control study 99 type 2 DM patients with suboptimal glycemic control Cumin essential oil 50 and 100 mg/day for 8 weeks Reduction of fasting blood glucose and glycosylated hemoglobin (HbA1C)
Diabetes mellitus Bilal et al., 2009 Randomized control study 41 type 2 DM patients Black cumin essential oil 700 mg/day for 40 days Reduction of fasting blood glucose
Diabetes mellitus Jafari et al., 2017 Randomized control study 64 prediabetic patients Cumin essential oil 75 mg/day for 10 weeks No significant change in glycemic indices; significant improvement of lipid profile
Diabetes mellitus, Dyslipidemia Keihan et al., 2016 Randomized control study 95 diabetic and dyslipidemic patients Cumin essential oil 25 mg/day for 90 days Reduction of fasting blood glucose, HbA1C, triglycerides and oxidized LDL
Dyslipidemia Hadi et al., 2018 Meta-analysis 6 RCTs with 376 patients Cumin essential oil Significant reduction of total cholesterol and LDL
Metabolic syndrome Morovati et al., 2019 Randomized control study 56 patients with metabolic syndrome Cumin essential oil 75 mg t.i.d. for 8 weeks Reduction of fasting blood glucose and total cholesterol